Controlled ovarian hyperstimulation with gonadotropinsfor Clomiphene Citrate resistant Polycysticovary syndrome leads to a higher risk of ovarianhyperstimulation syndrome

Controlled ovarian hyperstimulation with gonadotropinsfor Clomiphene Citrate resistant Polycysticovary syndrome leads to a higher risk of ovarianhyperstimulation syndrome

Ovarian hyperstimulation syndrome (OHSS) caused by controlled ovarian hyperstimulation ,although usually regressingspontaneously, may occasionally occur with clomiphene citrate, typically with gonadotropin, which sometimes results in seriouscomplications. 25-year-old patient was followed up in our hospital due to OHSS. Since our patient was Clomiphene Citrate (CC)resistant Polycystic ovary syndrome (PCOS), follitropin alpha was started. Firstly, treatment started from 75 IU rFSH. Increasedto 150 IU on day 15, if no improvement in the ovaries. Due to the development of two 18 mm follicles on the 21st day and theE2 value being 773 pg/mL, human chorionic gonadotropin (hCG) was applied and insemination was performed. Patients with CCresistant PCOS represent a challenge for reproductive medicine. We propose a calculated low-dose stimulation strategy with step up according to ovarian response in gonadotropins protocols. If the treatment period is extended and the dose is increased; Even ifthe follow-up values are normal, the patient should be closely monitored to avoid OHSS.

___

  • 1. Azziz R,Woods K, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-9.
  • 2. Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What’s new? Adv Clin Exp Med 2017;26:359-67.
  • 3. Brown J, Farquhar C, Beck J, et al. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 2005;1:CD002249.
  • 4. Neulen J, Yan Z, Raczek S, et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;80:1967-7.
  • 5. Kalem M, Kalem Z, & Gurgan T. Problems and Complications During the Treatment of Infertility in Women with Polycystic Ovary Syndrome. Gynecol Obstet Reprod Med 2016;22:113-24.
  • 6. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproduction technologies: prevention and treatment. Fertil Steril 1992;58:249- 61.
  • 7. Bergh PA, Navot D. Ovarian hyperstimulation syndrome: A review of pathophysiology. J Assist Reprod Genet 1992;9:429-38.
  • 8. Whelan JG, 3rd, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril 2000;73:883- 96.
  • 9. Polishuk WZ, Schenker JG. Ovarian overstimulation syndrome. Fertil Steril 1969;20:443-50.
  • 10. Rizk B, Aboulghar M, Smitz J, et al. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update 1997;3:255-66.
  • 11. Delbaere A, Bergmann PJM, Gervy-Decoster C, et al. Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Hum Reprod 1997;12:236-40.
  • 12. Abd Elgafor I. Efficacy of combined metforminletrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome. Arch Gynecol Obstet 2013;288:119-23.
  • 13. Cupisti S. Komplikation bei Ovulations induktion. Das ovarielle Überstimulationssyndrom. Geburtshilfe Frauenheilkd 2012;72:798-801
  • 14. Yildizhan R, Adali E, Kolusari A, et al.Ovarian Hyperstimulation Syndrome with pleural effusion: A case report. Cases J 2008;1:323
  • 15. Gulerman C, Yilmaz, N, Sargin Oruc, et al. Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome. Gynecol Obstet Reprod Med 2016;19:176-9.
Annals of Medical Research-Cover
  • Yayın Aralığı: Aylık
  • Yayıncı: İnönü Üniversitesi Tıp Fakültesi
Sayıdaki Diğer Makaleler

Oxidant and antioxidant levels in patients diagnosed withacute coronary syndrome at the emergency department

Mustafa AVCI, Hamit Yaşar ELLİDAĞ, Yavuz YILMAZ, Nalan KOZACI, Selma TEKKANAT, Fatih SELVİ

Periprosthetic joint infections are different from osteosynthesis-associated infections

Erman CEYHAN, Güzelali ÖZDEMİR, Niyazi Erdem YAŞAR, Alper DEVECİ, Olgun BİNGÖL, Sualp TURAN

Commonly administered physiotherapy techniques inthoracic surgery clinics in Turkey

Osman YAKŞİ, Mehmet ÜNAL, Ali KILIÇGÜN, Alp ÖZEL

Prevalence of toxoplasma, cytomegalovirus and rubella inpregnant women in Erzurum, Turkey

Ahmet YILMAZ, Mahmut UÇAR

A rare cause of dyspnea: Isolated congenitally correctedtransposition of the great arteries

Erkan YILDIRIM, Siho HİDAYET, Zeynep ULUTAŞ, Hasan ABDELRAHMAN

The effect of periodontal treatment on depression, bodyimage, self esteem and anxiety in individuals:A randomized controlled clinical trial

Hatice BALCI YÜCE, Osman DEMİR, Özge GÖKTÜRK, Sema İNANIR, Hümeyra AYDEMİR TÜRKAL

Epidemiological characteristics of patients with Covid-19suspicion applying to a university hospital: The first eightydays in a pandemic

Mustafa Kürşat AYRANCI, Kadir KÜÇÜKCERAN, Sevgi PEKCAN, Lütfi Saltuk DEMİR, Mehmet UYAR, Mehmet ÖZDEMİR, Mehmet BİÇER, Yasemin Derya GÜLSEREN, Yasemin DURDURAN, Özge METİN AKCAN, Sedat KOÇAK, Esma KEPENEK KURT, Bahar KANDEMİR, İbrahim ERYAMAN, Tevfik KÜÇÜKKARTALLAR, Reyhan EVCİ, Bahadır FEYİZOĞLU, M

Comparative study of multiple sclerosis patients based ondistance from the advanced health center

Mehmet TECELLİOĞLU, Hatice TOSUN

Evaluation of drug poisoning cases in pediatric emergencydepartment

Kazım KUTLUTÜRK, Mehmet ASLAN

Effects of cardiac rehabilitation on cardiac autonomic functions in ankylosing spondylitis patients: A randomized controlled study

Yakup ERDEN, Ahmet Lütfü SERTDEMİR, Mükremin ÇOŞKUN, Hatice UĞURLU